Disclaimer: This article is based on actual news from the real world – honestly! However, it has been sprinkled with a healthy dose of satire.
Scientists at Texas A&M University have discovered a way to recharge aging cells using flowers so small they make human hair look like redwood trees. The breakthrough involves adding nanoflowers to stem cells, which then produce twice the normal amount of mitochondria before transferring them to damaged cells like tiny battery delivery trucks.
Somewhere in there are some flowers, I guess! (Soukar et al/PNAS)
Mitochondria serve as the powerhouse of cells, a fact you learned in seventh-grade biology and have been no doubt eagerly waiting your entire adult life to deploy in conversation. The organelles play important roles in fighting viruses, starving parasites, and synthesizing amino acids and sex hormones, making them responsible for approximately 60 percent of what keeps you alive and 40 percent of what makes you regret being alive.
The process could revolutionize treatment for Alzheimer’s disease, muscular dystrophy, and fatty liver disease, though researchers admit it still won’t help you remember where you parked.
Stem cells possess what Gaharwar calls “a homing ability,” meaning they naturally migrate toward damaged tissue like tiny paramedics who never get lost or stop for gas. Once they arrive, they attempt to regenerate the area by transferring mitochondria to stressed cells. The nanoflowers supercharge this process, enabling stem cells to produce double the normal quantity of mitochondria before making their deliveries. It’s essentially Amazon Prime for cellular energy, except the delivery is always on time and nothing arrives in a three times larger-than-necessary, crushed box.
Stanford professor Daria Mochly-Rosen, who co-wrote a book titled “The Life Machines,” called the research an important advance. “The fact that you can increase the number of mitochondria per cell is huge,” she said, using the academic equivalent of “Holy shit, this might actually work.” Her own research led her to conclude that understanding mitochondria can change the future of medicine, which would make this either a genuine breakthrough or an elaborate marketing campaign for “The Life Machines,” depending on your level of cynicism.
The method differs from existing mitochondria-boosting medications, most of which must be taken repeatedly because they don’t actually change how cells produce or maintain mitochondria. It’s the pharmaceutical equivalent of giving someone a fish instead of teaching them to fish, except the fish are microscopic energy factories and the teaching involves nanotechnology.
The research team plans to begin testing the technique in rats in January or February, which means humanity’s first battle in the war against aging will be won or lost by laboratory rodents. The team is collaborating with three other labs specializing in muscular dystrophy, fatty liver disease, and nervous system disorders, creating what amounts to a scientific Avengers team, except everyone wears lab coats instead of capes, and far fewer three-point stances are involved.
Keshav K. Singh, founding editor of the journal Mitochondrion and director of the University of Alabama’s Cancer Genetics Program, called the study promising but noted the long-term safety of molybdenum disulfide in humans remains unknown. Singh, who also founded a company, Yuva Biosciences, that developed products to fight hair loss and wrinkles using mitochondria, dreams of starting what he calls a human energy project. The company name sounds like either visionary medicine or an elaborate scheme to make everyone dependent on mitochondrial maintenance products. Whether these two things are mutually exclusive remains unclear.
The study was published in Proceedings of the National Academy of Sciences, which means it passed peer review and is now officially more legitimate than anything your Boomer relatives posted on Facebook about astrology, “detoxing,” and juice cleanses. Publication in PNAS represents a significant scientific achievement, suggesting the research survived scrutiny from experts who actually understand what molybdenum disulfide is. The findings will now enter the standard scientific process: replication attempts, follow-up studies, clinical trials, regulatory review, and approximately eight years of people asking, “Whatever happened to that mitochondria thing?” before it either revolutionizes medicine or quietly disappears into the graveyard of once promising preliminary research that didn’t pan out.
This story is based on fully factual news, but if we got it wrong, blame these guys, we’re just here to make it funny.
